000 | 01615 a2200493 4500 | ||
---|---|---|---|
005 | 20250513101901.0 | ||
264 | 0 | _c19961023 | |
008 | 199610s 0 0 eng d | ||
022 | _a0174-1551 | ||
024 | 7 |
_a10.1007/BF00203677 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAschauer, M | |
245 | 0 | 0 |
_aExtended infusion of rtPA lysis of pulmonary emboli: influence of time after onset of symptoms on outcome. _h[electronic resource] |
260 |
_bCardiovascular and interventional radiology _c |
||
300 |
_a288-90 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aPulmonary Artery _xdiagnostic imaging |
650 | 0 | 4 |
_aPulmonary Embolism _xdiagnostic imaging |
650 | 0 | 4 | _aPulmonary Wedge Pressure |
650 | 0 | 4 | _aRadiography |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 | _aThrombolytic Therapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
700 | 1 | _aPilger, E | |
700 | 1 | _aSzolar, D H | |
700 | 1 | _aFlueckiger, F | |
700 | 1 | _aHausegger, K | |
700 | 1 | _aStark, G | |
700 | 1 | _aGroell, R | |
700 | 1 | _aKlein, G E | |
700 | 1 | _aSchreyer, H | |
773 | 0 |
_tCardiovascular and interventional radiology _gvol. 18 _gno. 5 _gp. 288-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00203677 _zAvailable from publisher's website |
999 |
_c8840643 _d8840643 |